These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 8866312

  • 1. Plasminogen activator activity is decreased in rat gingiva during diabetes.
    Chang K, Rani AS, Chang K, Kumar S.
    J Periodontol; 1996 Aug; 67(8):743-47. PubMed ID: 8866312
    [Abstract] [Full Text] [Related]

  • 2. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy.
    Chang KM, Ryan ME, Golub LM, Ramamurthy NS, McNamara TF.
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):303-18. PubMed ID: 8829770
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
    Xiao Y, Bunn CL, Bartold PM.
    J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
    [Abstract] [Full Text] [Related]

  • 4. The expression of plasminogen activator system in a rat model of periodontal wound healing.
    Xiao Y, Li H, Bunn C, Bartold PM.
    J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
    [Abstract] [Full Text] [Related]

  • 5. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ, Ludowese C, Sinha AA, Estensen RD.
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [Abstract] [Full Text] [Related]

  • 6. Chemically-modified tetracycline normalizes collagen metabolism in diabetic rats: a dose-response study.
    Yu Z, Ramamurthy NS, Leung M, Chang KM, McNamara TF, Golub LM.
    J Periodontal Res; 1993 Nov; 28(6 Pt 1):420-8. PubMed ID: 8254459
    [Abstract] [Full Text] [Related]

  • 7. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model.
    Doxey DL, Cutler CW, Iacopino AM.
    J Periodontol; 1998 Feb; 69(2):113-9. PubMed ID: 9526909
    [Abstract] [Full Text] [Related]

  • 8. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 9. Assay method for single-chain urokinase-type plasminogen activator.
    Matsuo O, Ueshima S, Okada K, Fukao H, Ohgaki M, Watanabe R, Arimura H.
    Hematol Pathol; 1989 Aug; 3(3):137-42. PubMed ID: 2531734
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 11. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models.
    Hagiwara H, Kaizu K, Uriu K, Noguchi T, Takagi I, Qie YL, Seki T, Ariga T.
    Thromb Res; 2003 Oct; 111(4-5):301-9. PubMed ID: 14693179
    [Abstract] [Full Text] [Related]

  • 12. A clinical study of plasminogen activator activity in gingival tissue in dogs with gingivitis and periodontitis.
    Papadimitriou S, Tsantarliotou M, Makris G, Papaioannou N, Batzios Ch, Kokolis N, Dessiris A.
    Res Vet Sci; 2006 Apr; 80(2):189-93. PubMed ID: 16098551
    [Abstract] [Full Text] [Related]

  • 13. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P.
    EMBO J; 1997 May 01; 16(9):2319-32. PubMed ID: 9171346
    [Abstract] [Full Text] [Related]

  • 14. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
    Liang W, Chuan-Zhen L, Qiang D, Jian Q, Hui-Min R, Bao-Guo X.
    Brain Res; 2004 Jul 23; 1015(1-2):175-80. PubMed ID: 15223382
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM, Greco WR.
    Cancer Res; 1986 Apr 23; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [Abstract] [Full Text] [Related]

  • 16. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM, Elliott SF, Cawston TE.
    Arthritis Rheum; 2001 Sep 23; 44(9):2084-96. PubMed ID: 11592371
    [Abstract] [Full Text] [Related]

  • 17. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
    Finci Z, Nachshon I, Sharoni Y, Mayer M.
    Exp Hematol; 1986 May 23; 14(4):293-7. PubMed ID: 2938980
    [Abstract] [Full Text] [Related]

  • 18. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N, Buduneli E, Ciotanar S, Atilla G, Lappin D, Kinane D.
    J Clin Periodontol; 2004 Jul 20; 31(7):556-61. PubMed ID: 15191592
    [Abstract] [Full Text] [Related]

  • 20. Membrane-associated procollagenase of leukemic cells is activated by urokinase-type plasminogen activator.
    Santibañez JF, Martínez J.
    Leuk Res; 1993 Dec 20; 17(12):1057-62. PubMed ID: 8246609
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.